Company Description: Ibio, Inc. is located in Bryan, TX, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. Ibio, Inc. has 75 total employees across all of its locations and generates $2.37 million in sales (USD).
…
Just $139.99 *
| Year | Revenue |
|---|---|
| 2020 | 1.64 |
| 2021 | 2.37 |
Similarly Will iBio get government funding? However, even with the nearly $12 million in aggregate cash recovery the company will receive as part of the resolution of its lawsuit with Fraunhofer USA, iBio is only funded until the end of March 2023.
What does ibio company do? Company Overview
iBio is leveraging its FastPharming Technologies to develop novel biopharmaceuticals for respiratory and fibrotic disease indications, among others. The Company’s subsidiary, iBio CDMO LLC, provides FastPharming Contract Development and Manufacturing Services.
Additionally, What is ibio400?
[Available On-Demand] iBio is an innovator biologics company developing therapeutics and vaccines for the betterment of human and animal health with pipeline candidates targeting systemic sceleroderma (IBIO-100), COVID-19 (IBIO-200 and IBIO-201), and classical swine fever (IBIO-400).
Who owns iBio stock?
Top 10 Owners of Ibio Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| The Vanguard Group, Inc. | 4.75% | 10,357,682 |
| SSgA Funds Management, Inc. | 2.09% | 4,553,819 |
| Geode Capital Management LLC | 1.73% | 3,771,565 |
| Northern Trust Investments, Inc.(… | 0.87% | 1,901,858 |
